Patents Assigned to AFFINICON APS
  • Agents, uses and methods
    Patent number: 9724426
    Abstract: The present invention relates to agents comprising a binding moiety with binding specificity for SRCR domain 1 of the CD163 receptor, for use in medicine. The invention also relates to methods, uses, kits and compositions comprising such agents.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: August 8, 2017
    Assignees: AFFINICON APS, AARHUS UNIVERSITY HOSPITAL
    Inventors: Niels Jonas Heilskov Graversen, Pia Svendsen, Peter Astrup Christensen, Maciej Bogdan Maniecki, Søren Kragh Moestrup, Holger Jon Møller, Gabriele Anton
  • CD163-binding conjugates
    Patent number: 9476890
    Abstract: The present invention relates to haptoglobin-haemoglobin (Hp-Hb) complex or a part thereof or a mimic thereof being operably linked to a substance and capable of binding a CD163 receptor. Furthermore, the invention relates to a CD163 variant, membrane bound or soluble, capable of binding at least one haptoglobin-haemoglobin (Hp-Hb) complex, and the use of the Hp-Hb complex and the CD163 receptor for therapy.
    Type: Grant
    Filed: November 20, 2007
    Date of Patent: October 25, 2016
    Assignee: AFFINICON APS
    Inventors: Soren Moestrup, Holger J. Moller